Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$39.12 - $52.44 $330,759 - $443,380
8,455 Added 172.55%
13,355 $578,000
Q4 2023

Feb 14, 2024

SELL
$21.39 - $49.64 $522,857 - $1.21 Million
-24,444 Reduced 83.3%
4,900 $225,000
Q3 2023

Nov 15, 2023

BUY
$15.81 - $27.8 $283,805 - $499,037
17,951 Added 157.56%
29,344 $672,000
Q2 2023

Aug 14, 2023

SELL
$16.32 - $21.15 $236,329 - $306,273
-14,481 Reduced 55.97%
11,393 $187,000
Q1 2023

May 15, 2023

BUY
$16.88 - $34.24 $436,753 - $885,925
25,874 New
25,874 $462,000
Q3 2022

Nov 14, 2022

SELL
$4.3 - $30.85 $178,966 - $1.28 Million
-41,620 Reduced 33.19%
83,796 $2.05 Million
Q2 2022

Aug 15, 2022

BUY
$3.12 - $12.25 $231,435 - $908,680
74,178 Added 144.77%
125,416 $520,000
Q1 2022

May 16, 2022

BUY
$6.13 - $12.24 $133,388 - $266,342
21,760 Added 73.82%
51,238 $590,000
Q4 2021

Feb 14, 2022

BUY
$8.62 - $13.9 $254,100 - $409,744
29,478 New
29,478 $294,000
Q2 2021

Aug 16, 2021

SELL
$18.52 - $22.55 $1.24 Million - $1.51 Million
-66,852 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$20.25 - $39.49 $1.35 Million - $2.64 Million
66,852 New
66,852 $1.42 Million
Q3 2018

Nov 14, 2018

SELL
$26.99 - $35.85 $209,388 - $278,124
-7,758 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$17.02 - $35.2 $132,041 - $273,081
7,758 New
7,758 $243,000

Others Institutions Holding RYTM

About RHYTHM PHARMACEUTICALS, INC.


  • Ticker RYTM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,720,000
  • Market Cap $3.18B
  • Description
  • Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...
More about RYTM
Track Paul Tudor Jones's Portfolio

Track Paul Tudor Jones Portfolio

Follow Paul Tudor Jones (Tudor Investment Corp Et Al) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.